Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials

医学 内科学 安慰剂 科克伦图书馆 糖尿病 不利影响 随机对照试验 餐后 临床试验 2型糖尿病 1型糖尿病 荟萃分析 梅德林 胃肠病学 置信区间 相对风险 胰岛素 内分泌学 替代医学 病理 政治学 法学
作者
Giovanni Musso,Roberto Gambino,Maurizio Cassader,Elena Paschetta
出处
期刊:BMJ [BMJ]
卷期号:: l1328-l1328 被引量:88
标识
DOI:10.1136/bmj.l1328
摘要

Abstract Objective To assess the efficacy and safety of dual sodium glucose cotransporter (SGLT) 1/2 inhibitor sotagliflozin in type 1 diabetes mellitus. Design Meta-analysis of randomised controlled trials. Data sources Medline; Cochrane Library; Embase; international meeting abstracts; international and national clinical trial registries; and websites of US, European, and Japanese regulatory authorities, up to 10 January 2019. Eligibility criteria for selecting studies Randomised controlled trials evaluating the effect of sotagliflozin versus active comparators or placebo on glycaemic and non-glycaemic outcomes and on adverse events in type 1 diabetes in participants older than 18. Three reviewers extracted data for study characteristics, outcomes of interest, and risk of bias and summarised strength of evidence using the grading of recommendations assessment, development, and evaluation approach. Main outcomes were pooled using random effects models. Results Of 739 records identified, six randomised placebo controlled trials (n=3238, duration 4-52 weeks) were included. Sotagliflozin reduced levels of glycated haemoglobin (HbA1c; weighted mean difference −0.34% (95% confidence interval −0.41% to −0.27%), P<0.001); fasting plasma glucose (−16.98 mg/dL, −22.1 to −11.9; 1 mg/dL=0.0555 mmol/L) and two hour-postprandial plasma glucose (−39.2 mg/dL, −50.4 to −28.1); and daily total, basal, and bolus insulin dose (−8.99%, −10.93% to −7.05%; −8.03%, −10.14% to −5.93%; −9.14%, −12.17% to −6.12%; respectively). Sotagliflozin improved time in range (weighted mean difference 9.73%, 6.66% to 12.81%) and other continuous glucose monitoring parameters, and reduced body weight (−3.54%, −3.98% to −3.09%), systolic blood pressure (−3.85 mm Hg, −4.76 to −2.93), and albuminuria (albumin:creatinine ratio −14.57 mg/g, −26.87 to −2.28). Sotagliflozin reduced hypoglycaemia (weighted mean difference −9.09 events per patient year, −13.82 to −4.36) and severe hypoglycaemia (relative risk 0.69, 0.49 to 0.98). However, the drug increased the risk of ketoacidosis (relative risk 3.93, 1.94 to 7.96), genital tract infections (3.12, 2.14 to 4.54), diarrhoea (1.50, 1.08 to 2.10), and volume depletion events (2.19, 1.10 to 4.36). Initial HbA1c and basal insulin dose adjustment were associated with the risk of diabetic ketoacidosis. A sotagliflozin dose of 400 mg/day was associated with a greater improvement in most glycaemic and non-glycaemic outcomes than the 200 mg/day dose, without increasing the risk of adverse events. The quality of evidence was high to moderate for most outcomes, but low for major adverse cardiovascular events and all cause death. The relatively short duration of trials prevented assessment of long term outcomes. Conclusions In type 1 diabetes, sotagliflozin improves glycaemic and non-glycaemic outcomes and reduces hypoglycaemia rate and severe hypoglycaemia. The risk of diabetic ketoacidosis could be minimised by appropriate patient selection and down-titration of the basal insulin dose.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
大魔王发布了新的文献求助10
2秒前
flysky120发布了新的文献求助100
3秒前
噜噜关注了科研通微信公众号
7秒前
7秒前
酷波er应助Wwt采纳,获得10
8秒前
giserhan完成签到,获得积分10
8秒前
10秒前
10秒前
神勇的逊完成签到,获得积分10
10秒前
小蘑菇应助科研小贩采纳,获得10
11秒前
ll应助许吉旋采纳,获得10
12秒前
12秒前
Landscape发布了新的文献求助10
13秒前
14秒前
万能图书馆应助英勇笑萍采纳,获得10
15秒前
16秒前
17秒前
20秒前
不点发布了新的文献求助10
20秒前
20秒前
20秒前
21秒前
所所应助PDIF-CN2采纳,获得10
21秒前
量子星尘发布了新的文献求助10
22秒前
22秒前
23秒前
23秒前
sjckn应助xiaofeiyan采纳,获得20
23秒前
传奇3应助abcde采纳,获得10
25秒前
Rondab应助爱撒娇的惋清采纳,获得30
26秒前
科研小贩发布了新的文献求助10
26秒前
26秒前
27秒前
疯狂的鸣凤完成签到,获得积分10
27秒前
meimei发布了新的文献求助10
28秒前
虚拟莫茗发布了新的文献求助10
30秒前
31秒前
32秒前
33秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3971541
求助须知:如何正确求助?哪些是违规求助? 3516239
关于积分的说明 11181643
捐赠科研通 3251428
什么是DOI,文献DOI怎么找? 1795874
邀请新用户注册赠送积分活动 876110
科研通“疑难数据库(出版商)”最低求助积分说明 805245